Skip to content

APOTHEEK DE RAM

Active
Public limited companyfounded 1987active for 38 yearsAstridplein 8A, 2280 Grobbendonk, BelgiumKBO/BCE: BE 0432.895.063
Summary

The computed 12-month bankruptcy probability of APOTHEEK DE RAM is 1.6% (moderate). The 2024 annual accounts show equity of €87,940 and a net result of -€54,417. Equity is shrinking by about 5.6% per year across the filed financial years. Its solvency ranks better than 22% of 9,535 sector peers (NACE 47, financial year 2024). The company has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€573,756total assets 2024
Staff
3.5 FTE
Equity
€87,940
Loss
-€54,417
Turnover not published (abbreviated format)
Financial health
54 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
1.6%
Structure
Largest shareholder
De Spuydreef · 50%
Accounts 76 days overdue0 of 3 deeds read
Why 54raises riskFigures for financial year 2024 (filed 11-07-2025)Loss of €54,417 (financial year 2024)Equity €87,940 (15.3% of total assets)lowers riskLiquidity: current ratio 1.46, cash €193,600Show the evidence

Checked score

Score 2024
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 31% of its sector peers (NACE 47, micro)
Financial strength · tick = 2023
Weak
Solvency 40-7
equity 15.3% of total assets
Liquidity 56-21
short-term debt 67.2% · cash 33.7%
Profitability 7-41
return on assets -9.5%
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,196 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.7%▲ +0.5 percentage points vs 07-2025 09-2025: 0.7%● unchanged vs 08-2025 10-2025: 0.7%● unchanged vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025 12-2025: 0.7%● unchanged vs 11-2025 01-2026: 0.7%● unchanged vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 1.2%▲ +0.5 percentage points vs 07-2026 09-2026: 1.3%▲ +0.1 percentage points vs 08-2026 10-2026: 1.6%▲ +0.3 percentage points vs 09-2026highest value
Credit of up to €4,500 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity tight (current ratio 1.46, compared with 2.08 in 2023, below the usual 1.5; short-term debt: 67.2% and cash: 33.7% of total assets), and 84.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 31% on solvency, 62% on liquidity, 16% on profitability and 13% on growth.

The bankruptcy probability was computed on 14-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises riskneutral
raises risk · Figures for financial year 2024 (filed 11-07-2025)
NBB · annual accounts
raises risk · Loss of €54,417 (financial year 2024)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.46, cash €193,600
NBB · annual accounts
raises risk · Equity €87,940 (15.3% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 9535 sector peers (2024).
NBB · sector comparison
Position among 9535 sector peers
Solvency
better than 22%
← weakest strongest →
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 76 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline15-10-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-07-2025, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
21 days early
2023
79 days early
2022
70 days early
2021
82 days early
2020
47 days early
2019
4 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 49 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · abbreviated…
  2. Weakest financial yearnet -€54,417
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Caution: From profit to loss in 2024after €16,352 in 2023 -€54,417 View
  • Caution: Among the weakest 9% on net resultsector median €44,777 · 9,536 companies -€54,417 View
  • Caution: Accounts not fileddeadline was 31-07-2026 76 days late View

By topic

Financials

Financial year
2024
Total assets
€573,756
Loss
-€54,417
Solvency
15.3%
Total assets▼ 11.7%
Net result
20182024
Go to Financials

Timeline

Events
39
Since
1989
  1. 22-05-2023Annual accounts filed
  2. 31-12-2022Highest result from 2018 to 2024
  3. 10-05-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
30-12-1987
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.